ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,854 | -19.2% | 19,480 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $145,787 | +73.6% | 18,787 | +19.7% | 0.00% | – |
| Q1 2022 | $84,000 | -66.0% | 15,697 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $247,000 | -31.8% | 16,802 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $362,000 | +24.0% | 17,305 | +4.7% | 0.00% | +100.0% |
| Q2 2021 | $292,000 | -9.9% | 16,534 | +25.2% | 0.00% | 0.0% |
| Q1 2021 | $324,000 | -25.9% | 13,207 | +2.4% | 0.00% | -50.0% |
| Q4 2020 | $437,000 | +236.2% | 12,898 | +147.7% | 0.00% | +100.0% |
| Q3 2020 | $130,000 | -27.8% | 5,207 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $180,000 | – | 5,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
| Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
| Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
| Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
| Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
| VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
| Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
| Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |